Targeting the HGF/c-Met axis: state of play

Mol Cancer Ther. 2010 May;9(5):1077-9. doi: 10.1158/1535-7163.MCT-10-0122. Epub 2010 May 4.
No abstract available

Publication types

  • Comment
  • Editorial
  • Review

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Clinical Trials as Topic
  • Drug Delivery Systems / methods*
  • Gene Amplification
  • Hepatocyte Growth Factor / antagonists & inhibitors*
  • Hepatocyte Growth Factor / genetics
  • Humans
  • Mutation / physiology
  • Neoplasms / drug therapy*
  • Neoplasms / genetics
  • Proto-Oncogene Proteins c-met / antagonists & inhibitors*
  • Proto-Oncogene Proteins c-met / genetics
  • Signal Transduction / drug effects
  • Signal Transduction / physiology

Substances

  • Antineoplastic Agents
  • Hepatocyte Growth Factor
  • Proto-Oncogene Proteins c-met